Keywords: Daiichi Sankyo, Kixiana, VTE prevention, Japan

Daiichi Sankyo debuts Lixiana in Japan for VTE prevention after orthopedic surgery

Article | 20 July 2011

Building on its cardiovascular portfolio, Japanese drug major Daiichi Sankyo (TYO: 4568) has launched its anti-blood clotting drug Lixiana (edoxaban) in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Eisai

Go to company listing

Related Drugs

Lixiana

Go to drug listing